Evidence map›Paper›PMID 34482526›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022

Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain.

Vicente Guillem Porta, Carlos Camps, Miguel Ángel Climent Durán, Enrique Gallardo, Aránzazu González Del Alba, Martín Lázaro-Quintela, María José Méndez Vidal, Álvaro Pinto Marín, Javier Puente, Cristina Antón-Rodríguez and 5 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 2 countries.

Vicente Guillem PortaFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain. presidente@fundacioneco.es.ORCID http://orcid.org/0000-0001-6073-6798
Carlos CampsFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Miguel Ángel Climent DuránFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Enrique GallardoOncology Department, Parc Taulí Hospital Universitari. Institut d'Investigació I Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
Aránzazu González Del AlbaFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Martín Lázaro-QuintelaFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
María José Méndez VidalMedical Oncology Department, Maimonides Institute for Biomedical Research of Córdoba, Hospital Reina Sofía, Córdoba, Spain.
Álvaro Pinto MarínMedical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
Javier PuenteFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Cristina Antón-RodríguezUnidad de apoyo a La Investigación, Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.
Fernando Caballero-MartínezFacultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.
Francisco J Campos-LucasUnidad de Consultoría E Investigación en Salud, Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain.
Ilse LugoFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Álvaro RogadoFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Ignacio DuránFundación ECO (Excelencia Y Calidad de La Oncología), Madrid, Spain.
Universidad Francisco de Vitoria · ESFundación Instituto Valenciano de Oncología · ESHospital General Universitario De Valencia · ESHospital Universitario La Paz · ESHospital Universitario Puerta de Hierro Majadahonda · ESInstituto de Investigación Marqués de Valdecilla · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversitat Autònoma de Barcelona · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review current measures for renal cancer care and develop a comprehensive and updated list of measures for their practical use in Spain.

methodsThe study was developed by Fundación ECO, a Spanish foundation aiming to improve oncology quality of care. A systematic literature review was carried out to identify measures and knowledge gaps. A scientific committee composed of nine experts reviewed the literature findings and added measures. A preliminary list of 42 measures was evaluated with the Delphi method to gather feedback from 47 medical oncology experts in Spain. Experts scored the appropriateness of the measures and ranked their priority in two consecutive online surveys. The scientific committee reviewed the Delphi results and developed the measures. A technical group from Universidad Francisco de Vitoria conducted and oversaw the Delphi method.

resultsThe Delphi method led to consensus on all 42 measures. The scientific committee used a prioritisation matrix to select 25 of these measures for evaluating quality of care in renal cancer. These measures regarded structure, process, and outcome and covered general management, diagnosis, treatment, follow-up, and evaluation of health outcomes. Easy-to-use index cards were developed for all 25 measures, including their definition, formula, acceptable level of attainment, and rationale.

conclusionsThis manuscript aims to provide healthcare professionals with expert- and evidence-based measures that are useful for evaluating quality of care in renal cancer in Spain and cover all aspects and stages.

Indexed as

Delphi TechniqueQuality of Health CareHumansKidney NeoplasmsSpainDelphiIndicatorsMeasuresQuality of careRenal cancerSpain

Identifiers

PMID34482526
OpenAlexW3198204886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.